Plain-English translation of NCT06830499 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study is testing the Sapien 3, a heart valve that doctors can place without open-heart surgery using a catheter (a thin tube). Researchers want to understand whether this valve works safely and effectively in younger patients (ages 50β70) who have severe aortic valve narrowing, and how long the valve lasts over time.
Most heart valve procedures in younger patients have traditionally been done with open-heart surgery, but doctors are increasingly using catheter-based valves instead. However, this newer approach has not been thoroughly studied in younger, healthier patients or in those with a two-leafed aortic valve, leaving important questions about safety, effectiveness, and how long the valve will work.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
Participants will undergo the Sapien 3 valve replacement procedure, which involves inserting a catheter through blood vessels to place the new valve without open-heart surgery. You will return for follow-up visits after the procedure to have your heart checked with imaging and blood tests to ensure the valve is working properly and monitor how well it lasts over time. Some participants will be enrolled retrospectively (using existing medical records) while others will be followed prospectively (prospectively monitored going forward).
AI-generated summary from trial data Β· Aug 9, 2026 Β· Not medical advice
China